查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012685

門診手術中心市場：按服務類別、所有權類型、設施類型、手術室容量、支付方類型和手術專科分類－2026-2032年全球市場預測

Ambulatory Surgical Centers Market by Service Category, Ownership, Facility Type, Operating Room Capacity, Payer Type, Procedure Specialty - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年門診手術中心市場價值為 924.4 億美元，預計到 2026 年將成長至 1,006.5 億美元，複合年成長率為 9.67%，到 2032 年將達到 1,764 億美元。

主要市場統計數據
基準年 2025 924.4億美元
預計年份：2026年 1006.5億美元
預測年份 2032 1764億美元
複合年成長率 (%) 9.67%

對不斷發展的門診手術中心生態系統進行全面概述：揭示結構促進因素、臨床趨勢和策略挑戰。

隨著醫療服務提供者、保險公司和患者重新評估他們對醫療服務可近性、成本和便利性的期望，門診手術格局正在經歷持續的變革。門診手術中心正逐漸成為醫療服務連續性的關鍵樞紐，在低成本、高容量的環境下，選擇性且明確的手術比例不斷提高。本概述整合了該領域的結構性特徵，重點闡述了報銷機制與臨床能力之間的相互作用，並闡明了門診手術中心在醫療服務現代化進程中的定位。

臨床、技術和財務因素的整合正在重塑門診手術中心的營運、所有權結構和競爭力。

門診手術中心正處於多項變革的核心，這些變革正在全面重塑醫療程序的組織、提供和資金籌措方式。微創技術的創新，加上麻醉方案的改進和圍手術全期流程的數位化，正在擴大可在門診安全開展的手術範圍。同時，私募股權和綜合醫療保健系統正在重塑所有權結構，加速產業整合，並重新定義競爭格局。

分析 2025 年關稅措施對門診手術中心醫療設備採購、籌資策略和供應鏈風險管理的影響。

2025年關稅和新貿易措施的實施對舒張期手術中心生態系統產生了微妙而多方面的影響，主要體現在醫療設備定價、供應鏈韌性和籌資策略的調整。由於舒張期手術中心（ASC）依賴種類繁多的資本設備、耗材和植入式醫療設備，關稅結構的變化可能會改變單位規模經濟效益，造成採購緊張，並加速尋求供應鏈冗餘和近岸外包替代方案。

針對特定細分市場的策略性洞察，展示了服務類別、所有權結構、設施設計、手術室 (OR) 容量、支付方構成和治療專科如何推動差異化。

透過對關鍵細分維度進行績效分析，可以更全面地了解該行業的整體情況。每個維度在營運、合約和臨床專案開發方面都具有獨特的戰略意義。根據服務類別，市場參與企業可分為診斷服務和治療服務；前者強調快速處理能力和影像主導的工作流程，而後者則需要專門的庫存和專注於特定手術的臨床團隊。根據所有權結構，營運商涵蓋了企業所有權平台、醫院所有權營業單位和醫生所有權診所，每種所有權結構都會影響其獲得資金的管道、轉診模式和管治獎勵。

美洲、歐洲、中東和非洲以及亞太地區在優先事項和營運優勢方面的區域差異，正在影響 ASC 的部署和擴大策略。

區域趨勢對法律規範、報銷機制、資本流動和人才獲取有顯著影響，從而在全球範圍內造成了不同的策略挑戰。在美洲，人口趨勢以及關於醫療保健可近性和可負擔性的政策辯論正在加速向門診醫療的轉變，並推動對能夠承接以往在住院部進行的擇期手術的門診平台的投資。因此，該地區的醫療機構正優先考慮與保險公司簽訂合約、推行價格透明化措施以及最佳化患者體驗，以適應不斷變化的轉診模式。

醫療保健提供者和供應商之間的競爭動態和關係塑造了 ASC 的競爭優勢，包括競爭、技術利用和以結果為導向的夥伴關係。

競爭格局的特點是眾多成熟的醫療保健系統、專業的門診手術中心運營商、醫療設備製造商和垂直整合的服務供應商，它們各自為價值鏈帶來獨特的優勢。領先的臨床營運商透過標準化的臨床路徑、嚴格的認證以及對手術全期位化工具的投資來脫穎而出，這些工具能夠降低取消率並提高患者處理能力。同時，醫療設備和耗材供應商也擴大與醫療保健提供者合作，採用基於價值的合約和基於結果的採購模式。

ASC 營運商面臨的實際策略挑戰包括：加強臨床路徑、實現採購來源多元化、與基於價值的支付方建立關係以及最佳化人力資源模式。

產業領導者需要採取一系列切實可行的措施，以創造價值、管控風險並加速門診手術中心的永續成長。首先，將臨床路徑標準化與數位化預約系統和手術全期最佳化相結合，可以提高患者處理能力、減少取消預約，並在保持臨床療效的同時提升患者滿意度。其次，採購經理應審查籌資策略，納入總交付成本分析，並在適當情況下採用雙重供應商策略，從而保護營運免受貿易政策波動和供應鏈中斷的影響。

本節介紹了一種嚴謹的混合方法研究途徑，該方法結合了主要訪談、二手文獻整合、細分分析和情境壓力測試，以確保穩健性。

本研究結合定性和定量方法，以確保方法的嚴謹性，對研究結果進行三角驗證，並得出與經營團隊決策週期相符的可操作性見解。主要研究包括對臨床負責人、醫療機構管理人員、支付方和供應鏈高階主管進行結構化訪談，以了解他們對流程轉換、採購行為和營運限制的真實觀點。次要分析則利用同行評審的臨床文獻、監管指導文件、行業報告和公開的財務資訊披露，對觀察到的趨勢進行背景分析並檢驗主題模式。

策略要點的整合強調了臨床創新、卓越營運以及與保險公司的合作將如何決定 ASC 的長期成功。

總之，門診手術中心在現代醫療服務體系中佔據著至關重要的地位，它能夠提供更便捷的就醫途徑、降低單位成本，並為以患者為中心的醫療服務鋪平道路。該行業的未來將受到臨床創新、支付方機構設計、所有權結構演變以及供應鏈韌性的影響，其成功與否將取決於運營商整合卓越臨床水平、高效運營和戰略商業性合作的能力。領導者必須在應對短期營運壓力的同時，投資於實現長期差異化的能力建構。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依服務類別分類的門診手術中心市場

  • 診斷
  • 治療

第9章：門診手術中心市場：依所有權類型分類

  • 公司所有權
  • 醫院所有
  • 醫生所有

第10章：依設施類型分類的門診手術中心市場

  • 多學科部門
  • 單一醫療部門

第11章 以手術室容量分類的門診手術中心市場

  • 5人或以上
  • 1-2間房間
  • 3-4間房

第12章 按支付方分類的門診手術中心市場

  • 醫療補助
  • 聯邦醫療保險
  • 私人保險
  • 自費

第13章 依手術類別分類的門診手術中心市場

  • 牙科手術
  • 皮膚科
  • 耳鼻喉科
  • 胃腸病學
  • 婦科
  • 眼科
  • 整形外科
  • 疼痛管理
  • 整形外科
  • 泌尿系統

第14章 門診手術中心市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 門診手術中心市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 門診手術中心市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國門診手術中心市場

第18章：中國門診手術中心市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdventHealth Surgery Centers, LLC
  • Alliance HealthCare Services, Inc.
  • AmSurg Corporation
  • Ascension Surgery Centers, LLC
  • Aspen Healthcare Limited
  • Coast Surgical Partners, LLC
  • Corewell Health Ambulatory Surgery Centers, Inc.
  • Envision Healthcare Holdings, Inc.
  • Global Surgical Partners, LLC
  • HCA Healthcare, Inc.
  • IntegraMed America, Inc.
  • Medical Facilities Corporation
  • Northside Surgery Center Holdings, LLC
  • Nueterra Healthcare, LLC
  • OakBend Medical Center Ambulatory Surgery Centers, Inc.
  • Premier Surgical Partnership, LLC
  • SCA Health
  • SurgCenter Development, LLC
  • Surgery Partners, Inc.
  • Surgical Alliance Holdings, Inc.
  • Symbion, LLC
  • TeamHealth Holdings, Inc.
  • Tenet Healthcare Corporation
  • US Specialty Surgical Partners, LLC
  • United Surgical Partners International, Inc.
Product Code: MRR-436901065E18

The Ambulatory Surgical Centers Market was valued at USD 92.44 billion in 2025 and is projected to grow to USD 100.65 billion in 2026, with a CAGR of 9.67%, reaching USD 176.40 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 92.44 billion
Estimated Year [2026] USD 100.65 billion
Forecast Year [2032] USD 176.40 billion
CAGR (%) 9.67%

Comprehensive orientation to the evolving ambulatory surgical center ecosystem clarifying structural drivers, clinical migration trends, and strategic imperatives

The outpatient procedural environment is undergoing sustained transformation as providers, payers, and patients recalibrate expectations around access, cost, and convenience. Ambulatory surgical centers have emerged as a critical node in the care continuum, delivering a growing proportion of elective and well-defined procedures in lower-cost, high-throughput settings. This introductory overview synthesizes the structural drivers that define the sector, highlights the interplay between reimbursement design and clinical capability, and situates ASCs within broader healthcare delivery modernization efforts.

In recent years, capital deployment, technological diffusion, and clinical pathway redesign have accelerated the migration of appropriate procedures from inpatient settings to ambulatory platforms. Consequently, operators are adapting governance, staffing, and supply chain practices to meet higher volumes while preserving clinical quality and safety. As a result, stakeholders are prioritizing investment in procedural standardization, perioperative coordination, and data-driven performance management to realize operational efficiencies.

Looking ahead, the strategic significance of ambulatory surgical centers will be shaped by regulatory reforms, payer contracting innovation, and continued patient preference for convenience. Therefore, leaders must appreciate how shifts in reimbursement, workforce dynamics, and yet-unfolding technological advances converge to create new competitive contours and partnership opportunities across the care ecosystem.

Converging clinical, technological, and financial forces that are reshaping ambulatory surgical center operations, ownership models, and competitive dynamics

Ambulatory surgical centers are at the center of several transformative shifts that collectively reconfigure how procedural care is organized, delivered, and financed. Innovations in minimally invasive techniques, coupled with enhanced anesthetic protocols and digital perioperative pathways, have expanded the scope of procedures that are safely deliverable in ambulatory settings. Concurrently, private equity and integrated healthcare systems are reshaping ownership models, accelerating consolidation, and redefining the competitive landscape.

At the same time, payer innovation is driving new contracting approaches that favor site-of-care optimization and bundled payments, which in turn incentivize throughput, standardized pathways, and tighter care coordination. Technological advancements in telehealth and remote patient monitoring are extending the continuum of preoperative optimization and postoperative follow-up, reducing length-of-stay equivalents and enabling higher patient volumes without proportional increases in facility footprint.

Moreover, workforce dynamics and labor cost pressures are prompting ASCs to rethink staffing models and invest in automation and clinical decision support to sustain quality while managing margins. Taken together, these shifts create both opportunity and complexity: operators that align clinical protocols, digital enablement, and value-based contracting will capture disproportionate benefits, whereas those who lag risk margin compression and referral attrition.

Analysis of how 2025 tariff measures are influencing device sourcing, procurement strategies, and supply chain risk management across ambulatory surgical centers

The introduction of tariffs and new trade measures in 2025 has a nuanced and multifaceted impact on the ambulatory surgical center ecosystem, transmitted primarily through medical device pricing, supply chain resilience, and procurement strategy adjustments. Because ASCs rely on a diverse array of capital equipment, consumables, and implantable devices, changes in tariff structures can alter unit economics, create sourcing tensions, and accelerate the search for supply chain redundancy and nearshoring alternatives.

In practical terms, providers and group managers are evaluating vendor portfolios to identify cost-sensitive categories where import duties and cross-border logistics materially affect procurement costs. As a result, contracting teams are renegotiating long-term supply agreements, seeking price protection clauses, and incorporating total landed cost considerations into procurement decision trees. At the same time, treasury and capital planning functions are reassessing equipment replacement schedules to smooth cashflow impacts and preserve clinical capability.

Importantly, tariffs also act as a catalyst for strategic supplier diversification: organizations are increasing inventory visibility, qualifying secondary vendors, and exploring regional manufacturing partnerships to mitigate exposure to future trade policy volatility. Consequently, leadership teams must integrate tariff risk into scenario planning and supplier scorecards, balancing cost mitigation with the clinical imperative to maintain product quality and regulatory compliance.

Segment-specific strategic insights showing how service category, ownership structure, facility design, OR capacity, payer mix, and procedural specialties drive differentiation

A granular view of the sector emerges when performance is examined across core segmentation dimensions, each of which carries distinct strategic implications for operations, contracting, and clinical programming. Based on Service Category, market participants differentiate between Diagnostic and Therapeutic services, with the former emphasizing fast throughput and imaging-driven workflows while the latter requires inventory specialization and procedure-specific clinical teams. Based on Ownership, operators range from Corporate Owned platforms to Hospital Owned entities and Physician Owned practices, and each ownership configuration shapes capital access, referral patterns, and governance incentives in different ways.

Based on Facility Type, distinctions between Multi-Specialty and Single Specialty facilities determine case-mix complexity, scheduling flexibility, and the degree of protocol standardization that can be achieved. Based on Operating Room Capacity, facilities are categorized across Five Or More, One To Two, and Three To Four operating rooms, and room capacity directly correlates with throughput potential, staffing scale, and investment amortization. Based on Payer Type, provider economics are contingent on the composition of Medicaid, Medicare, Private Insurance, and Self-Pay volumes, which drive reimbursement variability and contracting leverage.

Based on Procedure Specialty, clinical focus areas such as Dental Surgery, Dermatology, ENT, Gastroenterology, Gynecology, Ophthalmology, Orthopedics, Pain Management, Plastic Surgery, and Urology introduce diverse equipment profiles, credentialing requirements, and post-acute care pathways. Across these segmentation vectors, the most effective operators tailor clinical protocols, supply chain arrangements, and commercial strategies to the unique drivers of their segment, leveraging specialization where clinical complexity and margin opportunity align while pursuing standardization where scale and throughput matter most.

Regionally differentiated priorities and operational levers across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine ASC deployment and scaling strategies

Regional dynamics exert considerable influence on regulatory frameworks, reimbursement design, capital flows, and talent availability, producing distinct strategic imperatives across global geographies. In the Americas, demographic trends and policy debates about access and affordability have accelerated outpatientization and favored capital deployment into ambulatory platforms that can absorb elective procedures previously performed in inpatient settings. Consequently, operators in this region prioritize payer contracting, price transparency initiatives, and patient experience design to capture shifting referral patterns.

In Europe, Middle East & Africa, regulatory heterogeneity and public-sector procurement norms create varied entry conditions; yet, the promise of efficiency gains from outpatient models is prompting pilot programs and public-private partnerships in multiple jurisdictions. As a result, providers are calibrating investment strategies to local reimbursement rules, clinical credentialing pathways, and infrastructure availability. In the Asia-Pacific region, rapid urbanization, rising private healthcare investment, and expanding insurance penetration are driving facility development and technology adoption, while workforce training and facility accreditation remain critical enablers of scalable growth.

Across all regions, cross-border considerations such as device supply, talent mobility, and regulatory harmonization shape strategic decisions. Therefore, multinational operators and investors must tailor go-to-market approaches to local regulatory ecosystems, payer behaviors, and cultural preferences regarding outpatient care, while leveraging global best practices in clinical governance and quality assurance.

Competitive dynamics and provider-supplier relationships shaping ASC advantage including consolidation, technology enablement, and performance-oriented partnerships

The competitive landscape is populated by an array of established healthcare systems, specialized ASC operators, device manufacturers, and vertically integrated service providers, each contributing unique capabilities to the value chain. Leading clinical operators distinguish themselves through standardized clinical pathways, robust credentialing, and investments in perioperative digital tools that reduce cancellation rates and enhance patient throughput. At the same time, device and consumables suppliers are increasingly partnering with providers on value-based contracts and outcomes-linked procurement models.

Strategic investors and corporate acquirers are deploying capital toward consolidation of regional platforms, seeking scale advantages in purchasing, staffing, and administrative services. In parallel, physician-owned practices and single-specialty facilities continue to command clinical leadership in niche areas where deep procedural expertise and reputation matter. Technology vendors that deliver interoperable electronic health records, scheduling optimization, and remote monitoring capabilities are emerging as critical enablers for operators attempting to scale without sacrificing clinical quality.

Finally, alliances between hospital systems and independent ASC networks are redefining referral patterns and enabling hybrid care models that combine inpatient and outpatient capacity. The most resilient companies will be those that synthesize clinical excellence, efficient operations, and flexible commercial models to respond to evolving payer demands and patient expectations.

Practical strategic imperatives for ASC operators to strengthen clinical pathways, diversify sourcing, secure value-based payer relationships, and optimize workforce models

Industry leaders must adopt a suite of pragmatic actions to capture value, manage risk, and accelerate sustainable growth within ambulatory surgical centers. First, integrating clinical pathway standardization with digital scheduling and perioperative optimization will improve throughput, reduce cancellations, and enhance patient satisfaction while protecting clinical outcomes. Second, procurement leaders should recalibrate sourcing strategies to incorporate total landed cost analytics and dual-sourcing where appropriate, thereby insulating operations from trade policy volatility and supply chain disruption.

Third, executives should pursue payer partnerships that align incentives around site-of-care efficiency and quality metrics, negotiating flexible contracting arrangements that reward outcomes rather than volume. Fourth, workforce planning must combine targeted recruitment, competency-based training, and selective automation to maintain care quality while managing labor cost pressures. Fifth, organizational leaders should evaluate ownership and partnership models-whether corporate, hospital, or physician aligned-to determine which structure best supports long-term referral stability and capital access.

Finally, leaders should invest in performance measurement systems that link clinical, financial, and patient-experience metrics to strategic decision-making. By implementing these measures, organizations can enhance operational resilience, improve clinical consistency, and position themselves to capitalize on continued outpatientization trends.

Description of a rigorous mixed-methods research approach combining primary interviews, secondary literature synthesis, segmentation analysis, and scenario stress testing to ensure robustness

This research combines qualitative and quantitative techniques to ensure methodological rigor, triangulate findings, and surface actionable insights that align with executive decision cycles. Primary research involved structured interviews with clinical leaders, facility administrators, payers, and supply chain executives to capture real-world perspectives on procedural migration, procurement behavior, and operational constraints. Secondary analysis drew on peer-reviewed clinical literature, regulatory guidance documents, industry reports, and publicly available financial disclosures to contextualize observed trends and validate thematic patterns.

Data synthesis employed a segmentation-first approach to identify differences across service category, ownership structure, facility type, operating room capacity, payer composition, and procedure specialty. Comparative regional analysis assessed regulatory environments, reimbursement dynamics, and capital market activity across the Americas, Europe, Middle East & Africa, and Asia-Pacific. To ensure robustness, findings were stress-tested through scenario analysis that examined sensitivity to key variables such as supply chain shocks, reimbursement changes, and labor market shifts.

Throughout the study, methodological safeguards included interview triangulation, source corroboration, and iterative validation with subject-matter experts to minimize bias and enhance applicability. The resulting insights prioritize operational levers and strategic options that are both implementable and sensitive to the regulatory and commercial realities confronting ASC stakeholders.

Synthesis of strategic takeaways highlighting how clinical innovation, operational excellence, and payer alignment will determine long-term ASC success

In conclusion, ambulatory surgical centers occupy a pivotal position in contemporary healthcare delivery, offering pathways to improved access, lower unit costs, and patient-centered procedural care. The trajectory of the sector is influenced by clinical innovation, payer design, ownership evolution, and supply chain resilience, and success will be determined by an operator's ability to integrate clinical excellence with efficient operations and strategic commercial alignment. Leaders must simultaneously manage near-term operational pressures while investing in capabilities that enable longer-term differentiation.

By aligning clinical pathways with digital enablement, optimizing procurement strategies under changing trade conditions, and engaging payers with outcome-oriented contracting, organizations can position themselves to capture the strategic benefits of outpatientization. Furthermore, careful attention to segmentation and regional dynamics will allow operators to match their value proposition to the specific demands of distinct payer mixes, procedural specialties, and regulatory contexts.

Ultimately, the ASC segment presents compelling opportunities for those that combine disciplined execution with thoughtful strategic investments, balancing quality, access, and financial sustainability to drive enduring competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ambulatory Surgical Centers Market, by Service Category

  • 8.1. Diagnostic
  • 8.2. Therapeutic

9. Ambulatory Surgical Centers Market, by Ownership

  • 9.1. Corporate Owned
  • 9.2. Hospital Owned
  • 9.3. Physician Owned

10. Ambulatory Surgical Centers Market, by Facility Type

  • 10.1. Multi-Specialty
  • 10.2. Single Specialty

11. Ambulatory Surgical Centers Market, by Operating Room Capacity

  • 11.1. Five Or More
  • 11.2. One To Two
  • 11.3. Three To Four

12. Ambulatory Surgical Centers Market, by Payer Type

  • 12.1. Medicaid
  • 12.2. Medicare
  • 12.3. Private Insurance
  • 12.4. Self-Pay

13. Ambulatory Surgical Centers Market, by Procedure Specialty

  • 13.1. Dental Surgery
  • 13.2. Dermatology
  • 13.3. Ent
  • 13.4. Gastroenterology
  • 13.5. Gynecology
  • 13.6. Ophthalmology
  • 13.7. Orthopedics
  • 13.8. Pain Management
  • 13.9. Plastic Surgery
  • 13.10. Urology

14. Ambulatory Surgical Centers Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Ambulatory Surgical Centers Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Ambulatory Surgical Centers Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Ambulatory Surgical Centers Market

18. China Ambulatory Surgical Centers Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AdventHealth Surgery Centers, LLC
  • 19.6. Alliance HealthCare Services, Inc.
  • 19.7. AmSurg Corporation
  • 19.8. Ascension Surgery Centers, LLC
  • 19.9. Aspen Healthcare Limited
  • 19.10. Coast Surgical Partners, LLC
  • 19.11. Corewell Health Ambulatory Surgery Centers, Inc.
  • 19.12. Envision Healthcare Holdings, Inc.
  • 19.13. Global Surgical Partners, LLC
  • 19.14. HCA Healthcare, Inc.
  • 19.15. IntegraMed America, Inc.
  • 19.16. Medical Facilities Corporation
  • 19.17. Northside Surgery Center Holdings, LLC
  • 19.18. Nueterra Healthcare, LLC
  • 19.19. OakBend Medical Center Ambulatory Surgery Centers, Inc.
  • 19.20. Premier Surgical Partnership, LLC
  • 19.21. SCA Health
  • 19.22. SurgCenter Development, LLC
  • 19.23. Surgery Partners, Inc.
  • 19.24. Surgical Alliance Holdings, Inc.
  • 19.25. Symbion, LLC
  • 19.26. TeamHealth Holdings, Inc.
  • 19.27. Tenet Healthcare Corporation
  • 19.28. U.S. Specialty Surgical Partners, LLC
  • 19.29. United Surgical Partners International, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AMBULATORY SURGICAL CENTERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES AMBULATORY SURGICAL CENTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA AMBULATORY SURGICAL CENTERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY CORPORATE OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY CORPORATE OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY CORPORATE OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY HOSPITAL OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY HOSPITAL OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PHYSICIAN OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PHYSICIAN OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PHYSICIAN OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY MULTI-SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY MULTI-SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY MULTI-SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SINGLE SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SINGLE SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SINGLE SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FIVE OR MORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FIVE OR MORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FIVE OR MORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY ONE TO TWO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY ONE TO TWO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY ONE TO TWO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY THREE TO FOUR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY THREE TO FOUR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY THREE TO FOUR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY MEDICAID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY MEDICAID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY MEDICAID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY MEDICARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY MEDICARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY MEDICARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PRIVATE INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PRIVATE INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SELF-PAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SELF-PAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SELF-PAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY DENTAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY DENTAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY DERMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY DERMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY ENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY ENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY ENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPHTHALMOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PLASTIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PLASTIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GCC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 148. GCC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 166. G7 AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 169. G7 AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. NATO AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 175. NATO AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 176. NATO AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 178. NATO AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES AMBULATORY SURGICAL CENTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA AMBULATORY SURGICAL CENTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY SERVICE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY FACILITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY OPERATING ROOM CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA AMBULATORY SURGICAL CENTERS MARKET SIZE, BY PROCEDURE SPECIALTY, 2018-2032 (USD MILLION)